Alkermes to Participate in the Goldman Sachs Healthcare Conference

<br /> Alkermes to Participate in the Goldman Sachs Healthcare Conference<br />

PR Newswire

DUBLIN

,

June 8, 2022

/PRNewswire/ —

Alkermes plc

(Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Goldman Sachs 43
^rd
Annual Global Healthcare Conference on

Wednesday, June 15, 2022

at

2:40 p.m. PT

(

5:40 p.m. ET

/

10:40 p.m. BST

). The live webcast may be accessed under the Investors tab on

www.alkermes.com

and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at

www.alkermes.com

.

Contact:

Alex Braun

Investor Relations

+1 781 296 8493